681673
Wnt拮抗剂III，Box5
The Wnt Antagonist III, Box5 controls the biological activity of Wnt. This small molecule/inhibitor is primarily used for Cancer applications.
别名:
Wnt拮抗剂III，Box5
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C30H50N6O13S2
分子量:
766.88
NACRES:
NA.77
UNSPSC Code:
12352200
Assay:
≥90% (HPLC)
Form:
lyophilized solid
Quality level:
Storage condition:
OK to freeze, protect from light
Quality Level
assay
≥90% (HPLC)
form
lyophilized solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
water: 4 mg/mL, DMSO: 50 mg/mL
shipped in
wet ice
storage temp.
−20°C
General description
一种Wnt-5a衍生的N-末端丁氧羰基-（Boc）保护的六肽，有效对抗A2058和HTB63黑色素瘤培养物中Wnt-5a介导的细胞活动，包括迁移、侵袭、钙反应和MARCKS磷酸化。用甲酰修饰取代N-末端Boc会产生一种称为Foxy5的肽，该肽以Frizzled-5-（Fzd-5/Frz-5）依赖的方式模拟而不是拮抗Wnt-5a的生物活性。肽序列在多个物种中都是保守的，包括人类、小鼠和大鼠，Box5有望通过直接FZD5结合发挥其作用，就像Foxy5一样。
Packaging
用惰性气体包装
Preparation Note
复溶后，等分并冷冻保存（-20°C）。贮备溶液在-20°C下可稳定保存至多3个月。
Other Notes
Jenei, V., et al. 2009.Proc.Natl.Acad.Sci. USA106, 19473.
Safholm, A., et al. 2006.J. Biol. Chem.281, 2740.
Safholm, A., et al. 2006.J. Biol. Chem.281, 2740.
t-Boc-NH-Met-Asp-Gly-Cys-Glu-Leu-CO₂H
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性：标准处理（A）
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Yiming Fang et al.
NPJ precision oncology, 8(1), 7-7 (2024-01-09)
Frequent relapse and chemoresistance cause poor outcome in ovarian cancer (OC) and cancer stem cells (CSCs) are important contributors. While most studies focus exclusively on CSCs, the role of the microenvironment in providing optimal conditions to maintain their tumor-initiating potential
Chao Liu et al.
Science advances, 9(4), eadd8977-eadd8977 (2023-01-28)
Cervical squamous cell carcinoma (CESC) is a prototypical human cancer with well-characterized pathological stages of initiation and progression. However, high-resolution knowledge of the transcriptional programs underlying each stage of CESC is lacking, and important questions remain. We performed single-cell RNA
Krishan G Jain et al.
American journal of physiology. Lung cellular and molecular physiology, 323(5), L515-L524 (2022-09-14)
Failure to regenerate injured alveoli functionally and promptly causes a high incidence of fatality in coronavirus disease 2019 (COVID-19). How elevated plasminogen activator inhibitor-1 (PAI-1) regulates the lineage of alveolar type 2 (AT2) cells for re-alveolarization has not been studied.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 681673-10MG | 04055977225211 |